Cours PHILIPS KON JUN9 Euronext Amsterdam
Actions
Equipement et technologie médicale avancés
CA 2024 * | 18,7 Md 20,14 Md 0 18,25 Md | CA 2025 * | 19,67 Md 21,18 Md 0 19,19 Md | Capitalisation | 22,5 Md 24,23 Md 0 21,96 Md |
---|---|---|---|---|---|
Résultat net 2024 * | 189 M 204 M - 184 M | Résultat net 2025 * | 1,15 Md 1,23 Md - 1,12 Md | VE / CA 2024 * | 1,47 x |
Dette nette 2024 * | 4,93 Md 5,31 Md 0 4,81 Md | Dette nette 2025 * | 4,62 Md 4,97 Md 0 4,51 Md | VE / CA 2025 * | 1,38 x |
PER 2024 * |
123
x | PER 2025 * |
22,2
x | Employés | - |
Rendement 2024 * |
3,44% | Rendement 2025 * |
3,62% | Flottant | 83,91% |
Dernier transcript sur PHILIPS KON JUN9
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Roy Jakobs
CEO | Chief Executive Officer | 50 | 01/01/10 |
Director of Finance/CFO | 62 | 01/01/87 | |
Shez Partovi
CTO | Chief Tech/Sci/R&D Officer | 57 | 22/03/21 |
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
David Pyott
BRD | Director/Board Member | 70 | 01/01/15 |
Sanjay Poonen
BRD | Director/Board Member | 55 | 01/01/22 |
Director/Board Member | 68 | 01/05/21 |
Varia. 1 janv. | Capi. | |
---|---|---|
+11,73% | 226 Md | |
+9,53% | 188 Md | |
+14,63% | 137 Md | |
+27,47% | 108 Md | |
-0,04% | 63,19 Md | |
+13,73% | 52,26 Md | |
+4,86% | 51 Md | |
+7,72% | 43,89 Md | |
+7,86% | 38,07 Md |